ФАРМАКОЭКОНОМИКА ПРИМЕНЕНИЯ ГЕПАТОПРОТЕКТОРОВ В ТЕРАПИИ ЛЕКАРСТВЕННОГО ПОРАЖЕНИЯ ПЕЧЕНИ ПОСЛЕ ХИМИОТЕРАПИИ

Acta Biomedica Scientifica

Дмитрий Дмитриевич Мориков¹  Дмитрий Михайлович Пономаренко¹  Елена Геннадьевна Морикова² 

[1] Иркутская государственная медицинская академия последипломного образования - филиал ФГБОУ «Российская медицинская академия непрерывного профессионального образования» Минздрава России;Иркутский авиационный завод - филиал ПАО «Корпорация «Иркут»

关键词: фармакоэкономика;    прямые затраты;    эффективность;    pharmacoeconomics;    direct costs;    efficiency;   

DOI  :  10.12737/article_59a614fb8002d5.90108157

学科分类：自然科学（综合）

来源: Scientific entre for Family Health and Human Reproduction Problems

【 摘 要 】

One of the major problems of modern oncology drug is liver damage, requiring additional costs for its treatment. The aim of our work was to study medical and economic efficiency of various schemes of hepatoprotective treatment of toxic liver damage. The paper presents the use of pharmacoeconomic studies in the treatment of hepatic drug-induced hepatitis, which occurs after chemotherapy in patients with Hodgkin's lymphoma. The study was conducted in the two comparison groups on a "cost - effectiveness". This method was chosen because it is in effect depending on the process (method), treatment was varied, as well as costs incurred. The unit of the effect of the number of days required for the relief of hepatic failure has been selected. Economic analysis of the work includes not only toxic hepatitis therapy, and treatment of any disease complications such as hepatic encephalopathy. The study revealed that the effectiveness of therapy increased 1.4 times and the economic costs were 51.8 % reduced with hepatoprotective drug "remaxol".

【 授权许可】

CC BY